Association Between Aortic Valve Mean Gradient and TAVR Outcomes: A Perspective From a Nationwide Registry
Abstract
Background Patients with severe aortic stenosis with very low resting aortic valve mean gradient (MG) are underrepresented in transcatheter aortic valve replacement (TAVR) studies. We investigated the association of resting aortic valve MG with post‐TAVR outcomes in a large nationwide cohort. Methods We included patients from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry with a self‐expanding Evolut TAVR (until December 2022) and eligible for 1‐year follow‐up without prior balloon aortic valvuloplasty, TAVR, or surgical aortic valve replacement. Results Among 80 429 patients (mean age, 80.7±7.9; women, 53.9%; high/extreme surgery risk, 51.2%) stratified into 6 echocardiographic resting aortic valve MG groups (10–
Fields of Study & Subjects
Cardiac Valve Diseases and Treatments
Congenital Heart Disease Studies
Aortic Disease and Treatment Approaches
Publication details
- Journal / source
- Journal of the American Heart Association
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Volume
- 15
- Issue
- 19
- Pages
- e047319–e047319
- Publication date
- 30 August 2026
- Language
- EN